⌘K

Login Start Free

Home/Filings/4/0001209191-17-041307

4//SEC Filing

Kite Pharma, Inc. 4

Accession 0001209191-17-041307

CIK 0001510580operating

View on SEC.gov Company Profile

Filed

Jun 21, 8:00 PM ET

Accepted

Jun 22, 2:44 PM ET

Size

7.3 KB

Accession

0001209191-17-041307

Insider Transaction Report

Form 4

Period: 2017-06-20

Kite Pharma, Inc.KITE

Director

Transactions

Award
Common Stock
2017-06-20+2,410→ 152,427 total
Award
Director Stock Option (Right to Buy)
2017-06-20+8,810→ 8,810 total
Exercise: $91.21Exp: 2027-06-19→ Common Stock (8,810 underlying)

Holdings

Common Stock
(indirect: By Spouse)
25,065

Footnotes (1)

[F1]The stock option shall vest in 12 successive equal monthly installments following the date of grant.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Kite Pharma, Inc.

CIK 0001510580

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001510580

Filing Metadata

Form type: 4
Filed: Jun 21, 8:00 PM ET
Accepted: Jun 22, 2:44 PM ET
Size: 7.3 KB

View on SEC.gov